News Releases
Sep 30 2003
Peregrine's Phosphatidylserine-Based Vascular Targeting Agent Technology Presented At Angiogenesis Conference
Sep 18 2003
Targeted Delivery of Tissue Factor Research Published in 'Cancer Research'
Sep 9 2003
Peregrine Researchers Receive Grant From Phillip Morris For Lung Cancer Research
Aug 13 2003
Tumor Necrosis Therapy Receives Marketing Approval for Advanced Lung Cancer In The People's Republic of China
Jul 14 2003
Peregrine's Vascular Targeting Agents Presented at American Association of Cancer Research Annual Meeting
Jul 14 2003
Peregrine's Vascular Targeting Agent Inhibits Growth of Breast Cancer Tumor Metastases by 50 Percent in Pre-Clinical Studies
Jul 10 2003
Peregrine Maintains Listing On Russell 2000 And 3000 IndexesR
Jul 8 2003
Peregrine's Vasopermeation Enhancement Agent Technology Highlighted In The Lancet Oncology
Jul 1 2003
Peregrine Announces Fiscal Year 2003 Year End Results And Operational Highlights
Jun 27 2003
Peregrine Pharmaceuticals Receives Over $4 Million in Cash